Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and Cancer
- Publisher:
- Springer
- Publication Type:
- Chapter
- Citation:
- Nutraceuticals and Cancer Signaling Clinical Aspects and Mode of Action, 2021, pp. 451-466
- Issue Date:
- 2021-09-25
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| Devkota2021_Chapter_TeaCatechinsIncluding-Epigallo.pdf | Published version | 686.8 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Catechins, a group of phenolic compounds (flavan-3-ols), are one of most widely studied plant secondary metabolites regarding their diverse pharmacological actions. Found in many foods and beverages including tea, catechins are reported to be useful for the prevention and treatment of cancer in in vitro and in vivo studies. Various signalling mechanisms have also been explored for the cancer chemopreventive activities of tea and tea catechins. However, the translational research on these compounds to clinical studies have not been performed in detail as compared to in vitro and in vivo studies. This chapter critically discusses the role of catechins in cancer prevention and treatment with special focus on their mechanism of action on signaling pathways.
Please use this identifier to cite or link to this item:
